Get started
Author

José Luis Morero

Observed names: J Morero, J. L. MORERO, J. Morero, J.L. Morero, Jose L Morero, Jose L. Morero, Jose Luis Morero, Joseé Luis Morero, José L Morero, José L. Morero, José Morero
OpenAlex ID: A5110952970
Risk of Recurrence in Patients With Surgically Resected Stage I Non-small Cell Lung Carcinomaa
2003 · Claudia Poleri, Joseé Luis Morero, et al. · CHEST Journal · 86
Extreme asthenozoospermia and chronic respiratory disease: a new variant of the immotile cilia syndrome
1990 · H. E. CHEMES, J. L. MORERO, et al. · International Journal of Andrology · 41
PDF
Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma
2014 · L.M. Krug, A.J. Wozniak, et al. · Lung Cancer · 31
Neoadjuvant Chemotherapy with Gemcitabine and Cisplatin in Stage IIIA/B Non-Small Cell Lung Cancer
2002 · Maximiliano Van Kooten, Moisés Rosenberg, et al. · Investigational New Drugs · 12
Argentine consensus recommendations for lung cancer screening programmes: a RAND/UCLA-modified Delphi study
2023 · Iris Boyeras, Javier Roberti, et al. · BMJ Open · 11
PDF
Influence of Apoptosis and Cell Cycle Regulator Proteins on Chemotherapy Response and Survival in Stage IIIA/IIIB NSCLC Patients
2007 · José L. Morero, Claudia Poleri, et al. · Journal of Thoracic Oncology · 11
[Malignant pleural mesotheliomas].
1998 · S Mercurio, C Poleri, et al. · PubMed · 5
B3-06: Interim safety results from TRUST, a global open-label study of erlotinib in patients with advanced non-small-cell lung cancer (NSCLC)
2007 · Andrea Ardizzoni, Evangelia Razis, et al. · Journal of Thoracic Oncology · 4
PDF
Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma (MPM).
2012 · Lee M. Krug, Antoinette J. Wozniak, et al. · Journal of Clinical Oncology · 3
Phase II study of induction chemotherapy with gemcitabine (Gemtro®) (G) and cisplatin (C) in patients (pts) with stage IIIA–IIIB non-small cell lung cancer (NSCLC)
2000 · M van Kooten, M Rosenberg, et al. · Lung Cancer · 3
PP.50 Implementation of an Institutional Lung Cancer Screening Program Using Low-Dose Computed Tomography in Argentina
2023 · María Delfina Peralta Tanco, Diego Hernán Enrico, et al. · Journal of Thoracic Oncology · 1
PDF
Asthma admissions: Characteristics of patients admitted to a specialized respiratory hospital
2013 · Fabían Caro, Santiago Auteri, et al. · European Respiratory Journal · 1
[Pulmonary infiltrates in cancer patients].
2008 · Fernando A Díaz Couselo, José L Morero, et al. · PubMed · 1
P1.020: Collaborative Registry of LCS in Argentina: Lung Cancer Screening (Lu.Ca.S.) Project.
2026 · I.D. Boyeras Navarro, S. Lamot, et al. · Journal of Thoracic Oncology
Update Lung cancer Screening (LuCaS) project in Argentina.
2026 · Sebastian Lamot, Iris Boyeras, et al. · European Respiratory Journal
P2.04B.01 Argentine Lung Cancer Screening Programes Collaborative Registry: The LuCaS.Ar Project
2024 · I. Boyeras Navarro, S. Defranchi, et al. · Journal of Thoracic Oncology
PDF
Comentarios Post Primer Congreso de Prevención y Genómica
2017 · Juan Lacava, Héctor Cutuli, et al. · Oncología Clínica
PDF
Levels of IL-8 and IL17-A in Sputum Samples From Severe Asthma Patients
2013 · Glenda Ernst, Auteri Santiago, et al. · CHEST Journal
PDF
[Bronchodilators in acute asthma: metered dose inhalers or wet nebulizations?].
2006 · Dora M Lombardi, Manuel Casuso, et al. · PubMed
P-608 Prognostic factors in resected stage I non small cell lung carcinoma (NSCLC): Multivariate analysis of 565 cases
2005 · A. Dujon, L. Thiberville, et al. · Lung Cancer
P-633 Influence of apoptosis and cell cycle regulator proteins onchemotherapy response and survival in IIIA/IIIB NSCLC patients
2005 · J. Morero, C. Poleri, et al. · Lung Cancer
P-642 Histopathological evaluation and prognostic value of apoptosis in NSCLC stage I
2003 · Claudia Poleri, Jose L. Morero, et al. · Lung Cancer
418 Paclitaxel (Ptx) and cisplatin (cDDDp) as neoadjuvant treatment in stage III non-small-cell lung cancer (NSCLC)
1997 · M. van Kooten, M. Rosenberg, et al. · Lung Cancer
Works count: 23
Citation count: 210
H-index: 6
I10-index: 6
Year
Topic
Type